What did @ubergooberlady actually say?
She kept it blunt: Ozempic's side effects include "the drizzling shits" and headaches. That's the core medical claim buried inside a longer story about hiring a new caregiver and taking a spontaneous drive near Walmart. She's lost 17 pounds on semaglutide after losing 19 on her own first, and she hints that GI trouble was enough to make her "homebound sometimes." The side effect disclosure is casual, personal, and unpolished, but that doesn't make it wrong.
To be clear, she's not claiming Ozempic cures diabetes or telling anyone what dose to take. She's narrating her lived experience, and the specific GI complaint she names, diarrhea, is one of the most documented adverse effects in the semaglutide literature. Give credit where it's due: she's not overpromising anything here.
Does the science back this up?
Yes, largely. Diarrhea is one of the most consistently reported GI side effects of semaglutide, and the clinical trial data backs her up without much qualification needed.
In the SUSTAIN and STEP trial programs, GI adverse events were the most common reason people discontinued semaglutide. Davies et al. (2021, The Lancet) reported diarrhea in roughly 20-30% of participants on semaglutide 1 mg, depending on dose and titration speed. The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) showed nausea and diarrhea were the most frequent adverse events in the weight-loss population, occurring in up to 30.5% of semaglutide users versus 15.9% on placebo.
The mechanism isn't mysterious. GLP-1 receptors are expressed throughout the gut. Semaglutide slows gastric emptying and affects intestinal motility, which translates directly into loose stools, urgency, and the kind of situation she's alluding to when she says the story will need a part two. Headaches are also reported, though less frequently, and the evidence there is softer.
What did they get wrong (or right)?
She got the diarrhea claim right. That's real, documented, and common enough that it shows up consistently in prescribing information and clinical trial data. Where things get vague is the headache claim, which she mentions quickly before dropping it. Headaches aren't a top-tier, well-characterized semaglutide side effect in the same way GI symptoms are.
The prescribing information for Ozempic lists headache as an adverse reaction, but the incidence rates are low and the causal pathway isn't as clean as the GI mechanism. It's not wrong to mention it, but stating it alongside diarrhea as an equivalent side effect gives it more weight than the evidence really supports.
She also frames her weight loss as 17 pounds on Ozempic after 19 pounds on her own, which is an honest, useful distinction. She's not attributing everything to the drug. That kind of transparency is actually rarer than it should be in GLP-1 content on TikTok. No false equivalencies, no miracle language. That's worth noting.
What should you actually know?
GI side effects from semaglutide are not fringe complaints, they are a primary reason people stop taking it. The STEP trials reported that roughly 7% of participants discontinued due to GI events (Wilding et al., 2021, NEJM). Slow dose titration significantly reduces severity, which is why most prescribing protocols start at 0.25 mg weekly before moving up.
If you are experiencing diarrhea severe enough to affect your daily life or mobility, that is a clinical conversation, not a TikTok comment section situation. Persistent diarrhea can affect electrolyte balance and hydration, particularly in people who are already managing other health conditions. A caregiver environment, like the one she describes, adds another layer of complexity to managing unpredictable GI symptoms.
Headaches are worth monitoring but are not well-understood as a direct semaglutide effect compared to the GI profile. Dehydration from GI losses could be a contributing factor, which ties back to the diarrhea issue anyway.
- Diarrhea on semaglutide is real and common, not anecdotal.
- Slow titration is the main clinical tool for reducing GI severity.
- Headaches are listed in prescribing information but have weaker mechanistic support than GI effects.
- Persistent or severe GI symptoms warrant a call to whoever is managing your prescription, not just toughing it out.